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Yellow fever virus (YFV) remains the cause of severe morbidity and mortality in South America and Africa. To
determine the evolutionary history of this important reemerging pathogen, we performed a phylogenetic analysis of
the largest YFV data set compiled to date, representing the prM/E gene region from 133 viral isolates sampled from 22
countries over a period of 76 years. We estimate that the currently circulating strains of YFV arose in Africa within the
last 1,500 years and emerged in the Americas following the slave trade approximately 300–400 years ago. These
viruses then spread westwards across the continent and persist there to this day in the jungles of South America. We
therefore illustrate how gene sequence data can be used to test hypotheses of viral dispersal and demographics, and
document the role of human migration in the spread of infectious disease.
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Introduction
Few diseases have attracted more attention from medical
historians than yellow fever (YF). It was one of the most
feared of epidemic diseases from the 15th to 19th centuries,
when large scale outbreaks in port cities of North and South
America, Africa, and Europe caused devastating mortality
and helped to shape the expansion of settlements and
colonial powers. The landmark studies of Walter Reed in
1900–1901 established that the disease was transmissible
among humans via Aedes aegypti mosquitoes [1]. Within one
year of Reed’s discovery, the disease was successfully
controlled in Cuba as a result of vigilant mosquito control
campaigns [2]. Twenty-eight years later, yellow fever virus
(YFV) became the ﬁrst mosquito-borne virus to be identiﬁed
[3]. Despite this legacy, YF is currently classiﬁed as a
reemerging disease and remains a signiﬁcant cause of
morbidity and mortality, with an estimated 200,000 cases
each year and 30,000 deaths [4,5]. Indeed, although a highly
effective vaccine is available, epidemiological data suggest an
alarming resurgence of virus circulation in West Africa over
the last 20 years [6,7]. The failure to implement sustained
vaccination programs reﬂects larger problems of poverty,
civil war, and the inaccessibility of rural areas where
outbreaks of the disease occur [8].
The agent of the disease, YFV, is a single-stranded, positive-
sense RNA virus with a genome of approximately 11 kb. The
virus is a member of the genus Flavivirus (family Flaviviridae),
which contains a number of important vector-borne human
pathogens, such as the dengue, Japanese encephalitis, and
West Nile viruses. Previous evolutionary studies suggest that
YFV originated in Africa, as the deepest phylogenetic split
among viral genotypes is between those isolates sampled from
East and West Africa [9–11]. What is less clear, however, is the
timing and mechanism by which YFV was introduced to the
Americas and whether the descendants of the earliest
imported viruses still circulate today.
The most commonly cited hypothesis of the origin of YFV
in the Americas is that the virus was introduced from Africa,
along with A. aegypti, in the bilges of sailing vessels during the
slave trade. Subsequent to devastating urban outbreaks
within port cities on both the east and west coasts of South
America, the virus established a sylvatic enzootic cycle within
the Amazon, Araguaia, and Orinoco river basins vectored by
Haemagogus and Sabethes mosquitoes [12,13]. Although the
hypothesis of a slave trade introduction is often repeated, it
has not been subject to rigorous examination using gene
sequence data and modern phylogenetic techniques for
estimating divergence times [14]. Determining the age of
American sylvan YFV is of particular interest given the virtual
disappearance of urban (human) YFV transmission in South
America in the 20th century. Although a small number of
sporadic cases have been reported from residents of urban
areas (three cases in 1942 in Sena Madureira, Acra, Brazil [15],
15 cases in 1954 in Trinidad [16], six cases in 1999 in Santa
Cruz de la Sierra, Bolivia [17]), there was no evidence for
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documented Aedes-vectored epidemic occurred in 1928 in Rio
de Janeiro [12]. However, the reinfestation of many densely
populated coastal cities with A. aegypti and the emergence of
dengue in the Americas indicates that surveillance and
monitoring of YF endemic/epidemic viral activity remains a
critical public health objective.
To provide an insight on the factors that inﬂuence the
emergence of YF in the two hemispheres and to determine
the time-scale of these events, we have performed an
extensive analysis of the evolutionary relationships and
dynamics of YFV. To achieve this, we assembled the largest
data set of viral isolates compiled to date, including samples
taken from a wide range of geographical localities and over
an extensive time-span. The fragment analyzed comprised
half of premembrane (prM) (containing an important
cleavage site for pr!M), and extended through the ﬁrst 112
amino acids of envelope (E). This region was chosen because
of the relatively large data set available from previous studies
[9–11,18–21]. Further, the prM and E genes are of interest
because of their critical role in immunity and infectivity, and
because they form the structural proteins of the virion
surface and are the primary antigens that induce protective
immunity. From these data we were able to infer the time-
scale and evolutionary history of YFV, and provide the ﬁrst
direct evidence to our knowledge that YFV was introduced to
the Americas during the slave trade.
Results/Discussion
We examined YFV isolates representing the global diversity
of the disease from the World Reference Center for Emerging
Viruses and Arboviruses at the University of Texas Medical
Branch, Galveston, Texas, United States. Novel sequence data
from 37 human isolates, 21 mosquito isolates, and four
vertebrate isolates was obtained for the prM/E gene region
(670 nucleotides [nt], genomic positions 641-1310). Inclusion
of an additional 71 prM/E sequences from GenBank resulted
in an alignment of 133 wild-type isolates representing 22
countries (14 African, eight South American). Table 1
provides summary details on the YFV isolates included in
this study (more details are available in Table S1).
Our phylogenetic analysis shows that YFV can be divided
into two geographic groups, with distinct viral lineages
observed in Africa and the Americas (Figure 1). The prM/E
phylogeny supports the major genotype and subclade
distinctions observed previously in phylogenies based on full
genome sequences [22], the complete E gene [9], and the 39
non-coding region [23]. Four key observations can be drawn
from the structure of the YFV phylogeny. (1) The American
isolates are monophyletic, (2) the American isolates are
divided into those from the east and west of the continent, (3)
the isolates from West Africa are most closely related to those
from the Americas, and (4) the isolates from East Africa are
the most divergent. Such a phylogenetic pattern is compat-
ible with the hypothesis that YFV arose in Africa, most likely
in the east of that continent, and was imported into the
Americas from West Africa, and then spread westwards across
the Americas. To further test this hypothesis, we constructed
a model tree in which both the African and American
lineages were monophyletic, which is compatible with the
theory that the viruses from these two continents have
evolved separately for a far longer period of time (an ‘‘ancient
origin’’ model). However, the likelihood of this phylogeny was
signiﬁcantly lower (p , 0.001) than that of the maximum
likelihood and maximum a posteriori (MAP) (‘‘recent origin’’)
trees, further supporting a more recent migration of YFV
from Africa to the Americas.
To investigate the timing of the introduction event to the
Americas more precisely, we imposed a time-scale on this
Table 1. Summary of Yellow Fever Virus prM/E Gene Sequences
Used in This Study
Country Years Number and Source
of Isolates (Human;
Mosquito; Monkey)
Angola 1971 1 (1; 0; 0;)
Burkina Faso 1983 2 (2; 0; 0)
Bolivia 1999 5 (5; 0; 0)
Brazil 1935–2000 40 (24; 15; 4)
Central African Republic 1980–1985 4 (0; 4; 0)
Colombia 1979–2000 3 (3; 0; 0)
Ecuador 1979–1997 3 (3; 0; 0)
Ethiopia 1961 2 (2; 0; 0)
Gambia 2001 1 (1; 0; 0)
Ghana 1927 1 (1; 0; 0)
Guinea Bassau 1965 1 (1; 0; 0)
Ivory Coast 1982–1999 2 (2, 0, 0)
Kenya 1993 1 (1; 0; 0)
Nigeria 1946–1991 10 (9; 1; 0)
Panama 1974 2 (2, 0, 0)
Peru 1977–1999 25 (24; 0; 0)
a
Senegal 1927–1992 8 (8; 0; 0)
Sudan 1940–2003 5 (5; 0; 0)
Trinidad 1954–1995 8 (1; 4; 3)
Uganda 1948–1972 4 (1; 2; 1)
Venezuela 1959–1998 4 (3; 1; 0)
Zaire 1958 1 (1; 0; 0)
aOne virus isolate obtained from a sentinel mouse.
doi:10.1371/journal.ppat.0030075.t001
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Author Summary
Throughout the 18th and 19th centuries, yellow fever was one of
the most dreaded of diseases in New and Old world port cities.
Large-scale epidemics of yellow fever helped shape colonial
expansion in both the Americas and in Africa, and the medical
and scientific developments associated with control of the virus
have been a favored topic of historians for many years. The most
commonly cited hypothesis of the origin of yellow fever virus (YFV)
in the Americas is that the virus was introduced from Africa, along
with Aedes Aegypti mosquitoes, in the bilges of sailing vessels during
the slave trade. Although the hypothesis of a slave trade
introduction is often repeated, it has not been subject to rigorous
examination using gene sequence data and modern phylogenetic
techniques for estimating divergence times. Herein we have
assembled a comprehensive data set of gene sequences for YFV,
which we used to infer the time-scale and evolutionary history of
YFV. These data show that the spread of YFV to the Americas
corresponds closely with the routes and timing of the slave trade.
Overall, this study demonstrates how molecular epidemiological
studies can provide new insight into debates on the origin and
spread of infectious disease.PLoS Pathogens | www.plospathogens.org May 2007 | Volume 3 | Issue 5 | e75 0670
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divergence using a Bayesian coalescent approach. Broadly
equivalent rates of nucleotide substitution were observed in
all data sets studied (countries, genotypes, continents),
although the small number of viruses from East Africa
precluded an analysis in this case (Table 2). Across all 133
YFV sequences as a whole, the mean substitution rate was 4.2
310
 4 substitutions per site, per year (subs/site/year), ranging
from 3.3 3 10
 4 (South America genotype I) to 8.0 3 10
 4
(Peru) subs/site/year. These rates are within the range seen in
other RNA viruses, including ﬂaviviruses [24]. These rates are
also unlikely to have been adversely affected by positive
selection on speciﬁc lineages or codons. Although the mean
ratio of nonsynonymous (dN) to synonymous (dS) substitu-
tions per site (ratio dN/dS) was markedly higher in the South
American isolates of YFV than in the African isolates,
suggesting that selective patterns differ according to local
transmission cycle, all dN/dS values were less than 0.2, which is
indicative of relatively strong purifying selection against
nonsynonymous change as commonly observed in arthropod-
borne RNA viruses. Further, signiﬁcant evidence of positive
selection (dN/dS . 1) was only observed at a single codon,
E100, in some data sets, most notably Peru.
From the substitution rates estimated above, the deepest
node on the YFV phylogeny, corresponding to the time of
origin of viral strains sampled here, has a mean age of 723
years (95% highest probability density [HPD] of 288–1,304
years). A similar time-scale was observed under models of
both constant population size (the best-ﬁt to the data in
hand) and a Bayesian skyline plot, indicating that these age
estimates are robust to the demographic model (unpublished
data). More importantly, the estimated mean divergence time
of the West African and South American clades was
approximately 470 years ago (95% HPD of 186 and 869
years, respectively), while the mean time of origin of both
South American genotypes was 306 years ago (95% HPD of
120 and 590 years). Taken together, these analyses suggest
that genetic diversity in the available sample of South
American YFV arose within the last three to four centuries
and provide compelling support for an initial introduction
during the period of the slave trade and ﬁrst contact between
the two continents. Furthermore, it appears that the
divergence of the two South American lineages occurred
shortly after their initial introduction and that they have
been maintained in the Americas ever since.
Of equal signiﬁcance, and no doubt a tribute to effective
public health measures, is the lack of evidence for subsequent
trafﬁc of viruses between the hemispheres since the advent of
the post-vaccine era. An outstanding issue, however, is why
the newly established sylvatic South American viruses have
failed to cause urban epidemics like those caused by their
sylvatic counterparts in West Africa. In West Africa, out-
breaks are reported on a nearly annual basis, and ﬁve large
West African cities have faced YF epidemics since 2001 alone
[7]. However, our analyses revealed no major difference in
evolutionary dynamics among viruses circulating in South
America or Africa, and neither population exhibited the
increases in virus diversity expected of epidemic expansion.
Indeed, for both regions, the sequence data supported either
a constant population size or a population growth rate with
an extremely low epidemic doubling time (e.g., ;26 years in
the case of YFV from Brazil). This suggests that viral
epidemiology in both regions is still dominated by sylvatic
transmission.
It is also likely that population subdivision has played a
signiﬁcant role in maintaining the relatively constant levels of
genetic diversity within YFV, as reﬂected in the clear
geographic structure of the phylogeny clades, which generally
consist of sequences from neighboring countries with little
mixing among them. Previous studies of the spatiotemporal
distribution of the two South American genotypes [25]
indicated that Peruvian YFV may persist in discrete enzootic
foci due to biogeographic barriers that inhibit movement of
both vectors and hosts. In contrast, YFV isolates obtained
Table 2. Evolutionary Rates and Divergence Times of Yellow Fever Viruses
Data Set (n) Demographic
Model
Epidemic Doubling
Time (Years)
a
Substitution Rate
(3 10
 4 subs/site/year)
a
Age (Years)
a dN/dS
Brazil (38) Exponential 26 (12, 211) 6.7 (3.7, 9.6) 96 (65, 143) 0.130
b
Peru (25) Constant NA 8 (3.4, 13.3) 58 (28, 107) 0.191
b
South America I (55) Exponential 22 (12, 91) 3.3 (1.7, 4.8) 136 (82, 210) 0.148
South America II (34) Constant NA 5.8 (1.9, 9.9) 92 (35, 198) 0.159
b
All South America (90) Constant NA 3.8 (2.3, 5.3) 306 (120, 590) 0.138
West Africa (25) Exponential 105 (24, 45) 5.5 (1.9, 9.5) 183 (90, 331) 0.07
East Africa (17)
c NA NA 5.5
c (1.9, 9.5) 148 (86, 429) 0.042
South America and West Africa (115) Constant NA 4.1 (2.6, 5.6) 470 (186, 869) 0.110
b
All data (133) Constant NA 4.2 (2.6, 5.8) 742 (299, 1387) 0.078
b
aFor all parameter estimates the 95% HPD values are given in parentheses.
bMean substitution rate taken from the West Africa data set and excluding the highly divergent Angola/1971 sequence.
cSignificant evidence for positive selection (p ¼ 0.095) at codon E100 under the single likelihood ancestor counting and/or random effects likelihood methods.
NA, not applicable.
doi:10.1371/journal.ppat.0030075.t002
Figure 1. MAP Phylogenetic Tree Based on 133 YFV prM/E Gene Sequences
The major geographic groupings of YFV are indicated and posterior probability values are shown for key nodes. In all cases, tip times correspond to the
dates (year) of virus sampling.
doi:10.1371/journal.ppat.0030075.g001
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dispersal over larger distances, suggesting higher rates of
virus trafﬁc within the YF endemic zone that can most likely
be attributed to human-aided transportation of virus-
infected vectors or hosts [26]. Interestingly, these higher
rates of virus trafﬁc and population mixing within Brazil
appear to correspond to marginally higher rates of popula-
tion growth (Table 2).
YF provides a powerful historical demonstration of how
the establishment of travel and trade routes between
countries has been accompanied by the spread of microbes
and their vectors. Global trade and transportation in the
modern era continues to facilitate the movement of
pathogens and vectors farther and faster than ever before,
thus altering the potential geographic distribution of
infectious diseases. During recent decades there have been
several documented cases of the human importation of YFV
to non-endemic areas. Since 1964, such episodes have
included at least nine documented cases of European and
North American tourists who have died as a result of YFV
infection after returning home from visits to the Congo,
Senegal, Mauritania, Gambia, Co ˆte d’Ivoire, Brazil, and
Venezuela [27–30]. These examples demonstrate that
although YFV continues to be exported outside of endemic
regions, conditions have not been favorable to support
secondary transmission. Why YFV has not successfully
dispersed to new regions infested with A. aegypti, in particular
Asia, remains uncertain, although it is clear that previous
geographic barriers that prevented spread of YF in the past
are quickly eroding.
Materials and Methods
Viruses used in this study. All virus isolates were available from the
World Reference Center for Emerging Viruses and Arboviruses at the
University of Texas Medical Branch, Galveston, Texas, United States
(see Table S1). The majority of isolates were obtained through
primary isolation in suckling mouse brain, followed by a single
passage in C6/36 cells. A smaller number of isolates had uncertain
(undocumented) passage histories, or as many as two to ten passages
in suckling mouse brain. The viruses used covered a sampling period
of 76 years: 16 isolates from 1927–1959, 19 isolates from 1960–1969,
25 isolates from 1970–1979, 21 isolates from 1980–1989, 46 isolates
from 1990–1999, and 6 isolates from 2000–2003. Importantly, all of
the South American isolates represented sylvatic transmission cycles,
as no YFV isolates representing human-mosquito-human trans-
mission in South America are available in historical or contemporary
archives.
Sequence analysis. Maximum likelihood phylogenetic trees were
inferred for the YFV prM/E sequence data (670 nt) set under a variety
of nucleotide substitution models in PAUP* [31], including (a) codon-
speciﬁc substitution rates and (b) the GTRþIþC4 model, with the rate
of each substitution type under the general reversible model (GTR),
the proportion of invariant sites (I), and shape parameter of a gamma
distribution with four rate categories (C4) estimated from the data.
The GTRþIþC4 substitution model was also used as the basis to
estimate trees using Bayesian Markov chain Monte Carlo approaches
implemented in MrBayes [32] and BEAST [33]. The ﬁnal tree
presented is the MAP tree estimated in BEAST (chain length of 25
million, sampling every 1,000), with tip times corresponding to the
year of virus sampling.
To test the competing hypotheses of the ‘‘recent’’ and ‘‘ancient’’
origin of YFV in the Americas, we compared the likelihood of the
maximum likelihood tree (‘‘recent origin’’) with that of a model tree
in which both the African and American lineages were monophyletic
(‘‘ancient origin’’) using a Shimodaira–Hasegawa test [34].
Rates of nucleotide substitution, the age of the most recent
common ancestor (MRCA), and demographic histories were esti-
mated for the whole data set and each geographic subset using
models that allow for rate variation among lineages under a relaxed
(uncorrelated exponential) molecular clock [14] implemented in
BEAST [33]. Four population dynamic models were investigated:
constant population size, exponential population growth, logistic
growth, and expansion growth. To conﬁrm the age of the MRCA of all
the YFV sequences analyzed, we also used the piecewise Bayesian
skyline plot [35], as this possesses the least constrained coalescent
prior. Akaike’s information criterion was used to determine the best-
ﬁt model, with uncertainty in parameter estimates reﬂected in the
95% HPD values, and all chains were run for sufﬁcient time to ensure
convergence. All estimates were again based on the GTRþIþC4 model
of nucleotide substitution.
Mean and site-speciﬁc selection pressures acting on YFV were
measured as the ratio of nonsynonymous (dN) to synonymous
substitutions (dS) per site estimated using the single likelihood
ancestor counting (all sequences) and random effects likelihood
(maximum of 50 sequences) methods, both incorporating the GTR
model with phylogenetic trees inferred using the neighbor-joining
method available at the Datamonkey facility [36].
Supporting Information
Table S1. Yellow Fever Virus prM/E Gene Sequences Used in This
Study
Found at doi:10.1371/journal.ppat.0030075.st001 (116 KB XLS).
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